CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 192 enrolled
Drug / intervention
Prenatal Vitamin +2 moredrug
Likely dose
Prenatal Vitamin 400IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00610688
NCT00610688Phase 3Completed

High Prevalence of Rickets and Subclinical Maternal and Childhood Vitamin D Deficiency in the Middle East: a Randomized Controlled Trial of Prenatal Vitamin D Supplementation to Prevent Vitamin D Deficiency in Mothers and Their Infants

Children's Hospital Medical Center, Cincinnati·interventional·Posted Feb 8, 2008·Updated Oct 19, 2021

In Brief

A Phase 3 clinical trial evaluating Prenatal Vitamin and Cholecalciferol (Vitamin D3) for Vitamin D Deficiency. Completed, enrolled 192 participants across 2 sites in 2 countries.

Detailed Summary

The purpose of this research study is to compare the effects of higher dose vitamin D with commonly recommended dose in pregnant women to see which is better in achieving and/or maintaining sufficient vitamin D blood levels during pregnancy and in newborn infants as well as improving growth in the infant.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Arab Emirates, United States

Timeline

Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 8, 2008
Enrollment StartJan 1, 2008
Primary CompletionJun 1, 2011
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 18.4 years ago

Interventions

Prenatal Vitamindrug

Once daily, prenatal vitamin containing 400IU of Vitamin D, until delivery

Cholecalciferol (Vitamin D3)drug

Once daily, 1600IU dose of Vitamin D from 12 weeks gestation to delivery

Cholecalciferol (Vitamin D3)drug

Once daily, 3600IU dose of Vitamin D, from 12 weeks until delivery